According to Demis Hassabis, CEO of DeepMind, AI advancements could potentially solve all diseases within the next 10-15 years by performing 'science at digital speed' (source: Reid Hoffman). This statement highlights the transformative potential of AI in drug discovery, which is crucial information for traders interested in biotech and AI sectors.